Authors' Reply to Noguchi et al. Comment on: "Differences in the Adverse Event Profiles of Sodium-Glucose Cotransporter 2 Inhibitors Used in Patients with Diabetes and Heart Failure: An Analysis Using the Japanese Adverse Drug Event Report Database". - Sakamoto T; Miyamoto H; Hashizume J; Akamatsu H; Akagi T; Kodama Y; Hamano H; Zamami Y; Ohyama K (Clinical drug investigation, 2025)